ACE2 and COVID-19: Overall, polymorphisms in ACE2 and TMPRSS2 genes influence susceptibility, symptoms, and severity of patients to COVID-19 among populations across different regions of the world, suggesting that these genes could be potential targets in development of treatment therapies for COVID-19.